Lisopress
Country: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Lisinopril dihydrate 21.77mg equivalent to 20 mg lisinopril;
Disponibbli minn:
Viatris Limited
INN (Isem Internazzjonali):
Lisinopril dihydrate 21.77 mg (equivalent to 20 mg lisinopril)
Dożaġġ:
20 mg
Għamla farmaċewtika:
Tablet
Kompożizzjoni:
Active: Lisinopril dihydrate 21.77mg equivalent to 20 mg lisinopril Excipient: Calcium hydrogen phosphate dihydrate Magnesium stearate Maize starch Mannitol Purified talc
Unitajiet fil-pakkett:
Blister pack, Al foil/PVC blister, 30 tablets
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Gedeon Richter Ltd-Chemical Work Subsidiary Company
Sommarju tal-prodott:
Package - Contents - Shelf Life: Blister pack, Al foil/PVC blister - 30 tablets - 36 months from date of manufacture stored at or below 25°C
Data ta 'l-awtorizzazzjoni:
1999-12-23
